Effect of inhaled pre-prandial human insulin plus metformin and glimepiride versus rosiglitazone plus metformin and glimepiride on HbA1c [proportion of glycosylated haemoglobin] in subjects with type 2 diabetes.
Phase of Trial: Phase III
Latest Information Update: 07 Sep 2018
At a glance
- Drugs Insulin (Primary) ; Glimepiride; Metformin; Rosiglitazone
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 13 Oct 2009 Actual patient number changed from 225 to 227 as reported by ClinicalTrials.gov.
- 24 Jun 2008 Actual end date (Mar 2008) added as reported by ClinicalTrials.gov.